Works matching AU Paterson, David L.

Results: 261
    1
    2
    3
    4
    5
    6
    7
    8

    Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.

    Published in:
    2018
    By:
    • Harris, Patrick N. A.;
    • Ben Zakour, Nouri L.;
    • Roberts, Leah W.;
    • Wailan, Alexander M.;
    • Zowawi, Hosam M.;
    • Tambyah, Paul A.;
    • Lye, David C.;
    • Jureen, Roland;
    • Tau H. Lee;
    • Mo Yin;
    • Izharuddin, Ezlyn;
    • Looke, David;
    • Runnegar, Naomi;
    • Rogers, Benjamin;
    • Bhally, Hasan;
    • Crowe, Amy;
    • Schembri, Mark A.;
    • Beatson, Scott A.;
    • Paterson, David L.;
    • Lee, Tau H
    Publication type:
    journal article
    9

    Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coli.

    Published in:
    2017
    By:
    • Minh-Duy Phan;
    • Nguyen Thi Khanh Nhu;
    • Achard, Maud E. S.;
    • Forde, Brian M.;
    • Kar Wai Hong;
    • Teik Min Chong;
    • Wai-Fong Yin;
    • Kok-Gan Chan;
    • West, Nicholas P.;
    • Walker, Mark J.;
    • Paterson, David L.;
    • Beatson, Scott A.;
    • Schembri, Mark A.;
    • Phan, Minh-Duy;
    • Nhu, Nguyen Thi Khanh;
    • Hong, Kar Wai;
    • Chong, Teik Min;
    • Yin, Wai-Fong;
    • Chan, Kok-Gan
    Publication type:
    journal article
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.

    Published in:
    2020
    By:
    • Tong, Steven Y. C.;
    • Lye, David C.;
    • Yahav, Dafna;
    • Sud, Archana;
    • Robinson, J. Owen;
    • Nelson, Jane;
    • Archuleta, Sophia;
    • Roberts, Matthew A.;
    • Cass, Alan;
    • Paterson, David L.;
    • Foo, Hong;
    • Paul, Mical;
    • Guy, Stephen D.;
    • Tramontana, Adrian R.;
    • Walls, Genevieve B.;
    • McBride, Stephen;
    • Bak, Narin;
    • Ghosh, Niladri;
    • Rogers, Benjamin A.;
    • Ralph, Anna P.
    Publication type:
    journal article
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: a prospective multicentre observational study.

    Published in:
    Infectious Diseases, 2024, v. 56, n. 4, p. 268, doi. 10.1080/23744235.2023.2294122
    By:
    • Peri, Anna Maria;
    • Rafiei, Nastaran;
    • O'Callaghan, Kevin;
    • Brischetto, Anna;
    • Graves, Bianca;
    • Sinclair, Holly;
    • Eustace, Matthew;
    • Lim, Karen;
    • Parkes-Smith, Jill;
    • Stewart, Adam;
    • Davidson, Natalie;
    • Tabah, Alexis;
    • Bergh, Haakon;
    • Chatfield, Mark D.;
    • Harris, Patrick N. A.;
    • Paterson, David L.
    Publication type:
    Article
    28
    29
    30
    31
    32

    Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)

    Published in:
    Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab387
    By:
    • Stewart, Adam G;
    • Paterson, David L;
    • Young, Barnaby;
    • Lye, David C;
    • Davis, Joshua S;
    • Schneider, Kellie;
    • Yilmaz, Mesut;
    • Dinleyici, Rumeysa;
    • Runnegar, Naomi;
    • Henderson, Andrew;
    • Archuleta, Sophia;
    • Kalimuddin, Shirin;
    • Forde, Brian M;
    • Chatfield, Mark D;
    • Bauer, Michelle J;
    • Lipman, Jeffrey;
    • Harris-Brown, Tiffany;
    • Harris, Patrick N A;
    • (ASID-CRN), MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria.

    Published in:
    Antibiotics (2079-6382), 2022, v. 11, n. 4, p. N.PAG, doi. 10.3390/antibiotics11040449
    By:
    • De Oliveira, David M. P.;
    • Keller, Bernhard;
    • Hayes, Andrew J.;
    • Ong, Cheryl-Lynn Y.;
    • Harbison-Price, Nichaela;
    • El-Deeb, Ibrahim M.;
    • Li, Gen;
    • Keller, Nadia;
    • Bohlmann, Lisa;
    • Brouwer, Stephan;
    • Turner, Andrew G.;
    • Cork, Amanda J.;
    • Jones, Thomas R.;
    • Paterson, David L.;
    • McEwan, Alastair G.;
    • Davies, Mark R.;
    • McDevitt, Christopher A.;
    • Itzstein, Mark von;
    • Walker, Mark J.
    Publication type:
    Article
    49

    Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model.

    Published in:
    Antibiotics (2079-6382), 2022, v. 11, n. 1, p. 101, doi. 10.3390/antibiotics11010101
    By:
    • Tait, Jessica R.;
    • Bilal, Hajira;
    • Rogers, Kate E.;
    • Lang, Yinzhi;
    • Kim, Tae-Hwan;
    • Zhou, Jieqiang;
    • Wallis, Steven C.;
    • Bulitta, Jürgen B.;
    • Kirkpatrick, Carl M. J.;
    • Paterson, David L.;
    • Lipman, Jeffrey;
    • Bergen, Phillip J.;
    • Roberts, Jason A.;
    • Nation, Roger L.;
    • Landersdorfer, Cornelia B.
    Publication type:
    Article
    50